Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.27B |
| 2 |
Microsoft
MSFT
|
+$452M |
| 3 |
Technology Select Sector SPDR Fund
XLK
|
+$427M |
| 4 |
RTX Corp
RTX
|
+$341M |
| 5 |
Health Care Select Sector SPDR Fund
XLV
|
+$333M |
Top Sells
| 1 |
AABA
Altaba Inc. Common Stock
AABA
|
+$268M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$181M |
| 3 |
BCR
CR Bard Inc.
BCR
|
+$134M |
| 4 |
IQVIA
IQV
|
+$128M |
| 5 |
LVLT
Level 3 Communications Inc
LVLT
|
+$121M |
Sector Composition
| 1 | Technology | 13.84% |
| 2 | Financials | 11.67% |
| 3 | Healthcare | 11.33% |
| 4 | Consumer Discretionary | 10.16% |
| 5 | Communication Services | 7.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2101
Quad
QUAD
$333M
| $452K | ﹤0.01% |
20,017
+4,783
| +31% | +$108K |
|
|
SAFE
2102
Safehold
SAFE
$1.18B
| $452K | ﹤0.01% |
8,224
-4,865
| -37% | -$267K |
|
2103
SiriusPoint
SPNT
$2.22B
| $452K | ﹤0.01% |
30,804
+29,024
| +1,631% | +$426K |
|
|
FRAN
2104
DELISTED
Francesca's Holdings Corporation
FRAN
| $452K | ﹤0.01% |
5,158
+145
| +3% | +$12.7K |
|
2105
First Bancorp
FBNC
$2.29B
| $451K | ﹤0.01% |
12,764
+10,204
| +399% | +$361K |
|
2106
Voyager Therapeutics
VYGR
$232M
| $451K | ﹤0.01% |
27,162
+12,525
| +86% | +$208K |
|
2107
Frontline
FRO
$5.17B
| $450K | ﹤0.01% |
98,055
-294,722
| -75% | -$1.35M |
|
2108
Supernus Pharmaceuticals
SUPN
$2.55B
| $450K | ﹤0.01% |
11,272
+7,964
| +241% | +$318K |
|
|
RP
2109
DELISTED
RealPage, Inc.
RP
| $450K | ﹤0.01% |
10,145
+8,606
| +559% | +$382K |
|
2110
Antero Midstream
AM
$8.91B
| $448K | ﹤0.01% |
+22,712
| New | +$448K |
|
2111
Fresenius Medical Care
FMS
$14.7B
| $447K | ﹤0.01% |
8,500
+2,536
| +43% | +$133K |
|
2112
Invesco Preferred ETF
PGX
$3.99B
| $446K | ﹤0.01% |
+30,000
| New | +$446K |
|
|
CDR
2113
DELISTED
Cedar Realty Trust, Inc
CDR
| $446K | ﹤0.01% |
11,120
+2,359
| +27% | +$94.6K |
|
|
HK.WS
2114
DELISTED
Halcon Resources Corporation
HK.WS
| $446K | ﹤0.01% |
676,281
| – | – |
|
|
ZAGG
2115
DELISTED
ZAGG Inc Common Stock (Delaware)
ZAGG
| $445K | ﹤0.01% |
24,023
+22,397
| +1,377% | +$415K |
|
|
SGG
2116
DELISTED
iPath Bloomberg Sugar Subindex Total Return ETN due June 24, 2038
SGG
| $445K | ﹤0.01% |
14,408
| – | – |
|
2117
NBT Bancorp
NBTB
$2.27B
| $442K | ﹤0.01% |
12,023
+11,034
| +1,116% | +$406K |
|
2118
Stoneridge
SRI
$228M
| $442K | ﹤0.01% |
19,332
+11,947
| +162% | +$273K |
|
|
ITCI
2119
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $442K | ﹤0.01% |
30,567
-34,031
| -53% | -$492K |
|
2120
CytomX Therapeutics
CTMX
$330M
| $441K | ﹤0.01% |
20,870
-6,516
| -24% | -$138K |
|
2121
Rithm Capital
RITM
$6.57B
| $441K | ﹤0.01% |
24,676
-52,450
| -68% | -$937K |
|
|
ECYT
2122
DELISTED
Endocyte, Inc. Common Stock
ECYT
| $441K | ﹤0.01% |
103,109
+103,078
| +332,510% | +$441K |
|
2123
Federal Signal
FSS
$7.64B
| $440K | ﹤0.01% |
21,895
+9,449
| +76% | +$190K |
|
2124
The Ensign Group
ENSG
$9.69B
| $439K | ﹤0.01% |
21,145
+19,951
| +1,671% | +$414K |
|
2125
MannKind Corp
MNKD
$1.71B
| $439K | ﹤0.01% |
189,138
+135,571
| +253% | +$315K |
|